formic acid has been researched along with Creutzfeldt-Jakob Syndrome in 4 studies
formic acid: RN given refers to parent cpd
formic acid : The simplest carboxylic acid, containing a single carbon. Occurs naturally in various sources including the venom of bee and ant stings, and is a useful organic synthetic reagent. Principally used as a preservative and antibacterial agent in livestock feed. Induces severe metabolic acidosis and ocular injury in human subjects.
Creutzfeldt-Jakob Syndrome: A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. (From N Engl J Med, 1998 Dec 31;339(27))
Excerpt | Relevance | Reference |
---|---|---|
"Formic acid pretreatment is considered to be effective in prion inactivation." | 5.33 | Tissue pretreatment with formic acid might lower HercepTest scores in breast cancer. ( Boesl, A; Burkhardt, M; Dahl, E; Dankof, A; Dietel, M; Fritzsche, FR; Kristiansen, G; Pahl, S, 2006) |
"Formic acid pretreatment is considered to be effective in prion inactivation." | 1.33 | Tissue pretreatment with formic acid might lower HercepTest scores in breast cancer. ( Boesl, A; Burkhardt, M; Dahl, E; Dankof, A; Dietel, M; Fritzsche, FR; Kristiansen, G; Pahl, S, 2006) |
"This formic acid pretreatment enhanced immunoreactivity of the amyloid deposits which reacted positively with specific antiserum." | 1.27 | Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. ( Kitamoto, T; Ogomori, K; Prusiner, SB; Tateishi, J, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zaborowski, A | 1 |
Kordek, R | 1 |
Botts, GT | 1 |
Liberski, PP | 1 |
Fritzsche, FR | 1 |
Kristiansen, G | 1 |
Boesl, A | 1 |
Burkhardt, M | 1 |
Pahl, S | 1 |
Dankof, A | 1 |
Dietel, M | 1 |
Dahl, E | 1 |
Van Everbroeck, B | 1 |
Pals, P | 1 |
Martin, JJ | 1 |
Cras, P | 1 |
Kitamoto, T | 1 |
Ogomori, K | 1 |
Tateishi, J | 1 |
Prusiner, SB | 1 |
4 other studies available for formic acid and Creutzfeldt-Jakob Syndrome
Article | Year |
---|---|
Immunohistochemical investigations of the prion protein accumulation in human spongiform encephalopathies. Special report II.
Topics: Antibodies, Monoclonal; Brain; Creutzfeldt-Jakob Syndrome; Formates; Gerstmann-Straussler-Scheinker | 2003 |
Tissue pretreatment with formic acid might lower HercepTest scores in breast cancer.
Topics: Breast Neoplasms; Creutzfeldt-Jakob Syndrome; Evaluation Studies as Topic; Female; Formates; Humans; | 2006 |
Antigen retrieval in prion protein immunohistochemistry.
Topics: Brain; Creutzfeldt-Jakob Syndrome; Epitopes; Formates; Histological Techniques; Hot Temperature; Hum | 1999 |
Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidosis; Animals; Creutzfeldt-Jakob Syndrome; | 1987 |